Format

Send to

Choose Destination
Nat Med. 2006 Apr;12(4):452-8. Epub 2006 Apr 2.

Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts.

Author information

1
Institute of Experimental and Clinical Pharmacology, University Medical Center Hamburg-Eppendorf, Germany. w.zimmermann@uke.uni-hamburg.de

Abstract

The concept of regenerating diseased myocardium by implantation of tissue-engineered heart muscle is intriguing, but convincing evidence is lacking that heart tissues can be generated at a size and with contractile properties that would lend considerable support to failing hearts. Here we created large (thickness/diameter, 1-4 mm/15 mm), force-generating engineered heart tissue from neonatal rat heart cells. Engineered heart tissue formed thick cardiac muscle layers when implanted on myocardial infarcts in immune-suppressed rats. When evaluated 28 d later, engineered heart tissue showed undelayed electrical coupling to the native myocardium without evidence of arrhythmia induction. Moreover, engineered heart tissue prevented further dilation, induced systolic wall thickening of infarcted myocardial segments and improved fractional area shortening of infarcted hearts compared to controls (sham operation and noncontractile constructs). Thus, our study provides evidence that large contractile cardiac tissue grafts can be constructed in vitro, can survive after implantation and can support contractile function of infarcted hearts.

PMID:
16582915
DOI:
10.1038/nm1394
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center